biphasic THC dose response low dose anti-inflammatory pain relief clinical

Low-Dose THC for Pain Relief: The Clinical Case

Kevin Menard, LAc.

|

|

Time to read 9 min

Key Takeaways

At low doses (2.5–5mg), THC produces analgesia through CB1 receptor activation without the psychoactive overstimulation of higher doses — the biphasic dose response means less is often more effective for pain

Low-dose THC addresses the central nervous system dimension of chronic pain that CBD cannot fully reach — particularly for neuropathic pain, where CB1 engagement in the spinal cord and brain is the primary pain modulation pathway

THC at low doses shortens sleep latency and deepens slow-wave sleep — critical for people whose chronic pain is disrupting the overnight repair cycle

The Leisure Gummies (5mg THC + 33mg CBD + CBC + CBG) deliver this at the clinical dose — the multi-cannabinoid formula covering ECS modulation from multiple receptor directions simultaneously

The Short Answer: THC has a biphasic relationship with pain: at low doses, it engages CB1 receptors in the brain's descending pain-control centers and in the dorsal horn of the spinal cord to reduce pain signal intensity and support anti-inflammatory ECS activity. At high doses, it can increase anxiety and paradoxically heighten pain sensitivity. Trace and low-dose THC — as found in full-spectrum CBD formulas — provides the analgesic benefit without the psychoactive ceiling that makes high-dose THC clinically unreliable for chronic pain management.

THC has an image problem in pain medicine, mainly due to Cannabis. It is either dismissed entirely by practitioners unfamiliar with the dose-response pharmacology, or self-administered at recreational doses that work against the clinical goal.

Both positions miss the same nuance. The research on low-dose THC for pain is clear and consistent: at trace and low doses, THC adds analgesic activity through CB1 receptor pathways that CBD alone does not engage through the same mechanism. The clinical question is not whether THC belongs in a pain protocol. It is at what dose, in what ratio, and in what delivery context it provides benefit without creating new problems.

CB1 receptor descending pain inhibitory pathway THC analgesia low dose

The Biphasic Dose Response: Why Low Is Different from High

THC is biphasic. Its effects reverse direction as the dose increases past an individual threshold.


At low doses, THC engages CB1 receptors in the brain's descending pain-control centers and in the dorsal horn of the spinal cord — the key nodes of the descending pain-inhibitory pathway. This CB1 engagement activates the body's internal pain-dampening network, reducing the intensity of pain signals before they reach conscious processing. The result is analgesia without significant psychoactivity, particularly when THC is paired with CBD in a full-spectrum formula.


At high doses, the same CB1 system becomes dysregulated. THC can increase sensory sensitivity, elevate anxiety, and in individuals with a tendency toward pain catastrophizing — the cognitive amplification of pain experience — actually worsen the overall pain perception. The recreational-level cannabis use that most patients associate with cannabis does not produce reliable chronic pain relief for this reason. The dose-response relationship is not linear.


Research consistently supports the superiority of full-spectrum, low-ratio THC formulas over high-THC or isolated approaches for most chronic pain presentations — a finding that maps directly to the biphasic pharmacology.

CBD and THC Together: Synergy at the Receptor Level

CBD and THC do not simply add to each other in a pain context. They modulate each other's activity.


CBD modulates CB1 receptor activity and limits THC's psychoactive ceiling through indirect mechanisms. This is why a formula with 25mg CBD and 2.5mg THC feels qualitatively different from 2.5mg THC consumed alone — the CBD creates a functional ceiling on the psychoactive effect while preserving and potentially amplifying the analgesic activity at CB1 pain pathways.


This receptor-level interaction is the clinical rationale for full-spectrum CBD formulas that include trace THC. The goal is not intoxication. The goal is CB1 engagement in the descending pain pathway — achieved at sub-psychoactive concentrations precisely because CBD is modulating the ceiling simultaneously.

Dragon Hemp Recovery Tincture trace THC full-spectrum CBD CBN pain formula

Trace THC in Full-Spectrum Pain Formulas

The Recovery Tincture delivers nano-emulsified full-spectrum CBD alongside nano CBN and trace non-intoxicating THC. The THC level is sub-psychoactive by design — sufficient to engage CB1 pain-inhibitory pathways without producing the ceiling effects associated with recreational dosing. Combined with the high CBD content, the psychoactive effect is modulated while the analgesic pathway remains active.


Nano-emulsification matters here specifically. THC in nano-emulsified form has significantly faster onset and more consistent bioavailability than THC in standard oil-based delivery. The trace amount present in the Recovery Tincture has more reliable analgesic activity than a larger dose delivered through conventional absorption — which means less THC is required to achieve the same clinical CB1 engagement.


CBN in the formula contributes to the full-spectrum analgesic profile through its interaction with the ECS, and early research suggests it may support pain modulation through pathways distinct from CBD — without introducing additional psychoactivity.

Deep, soothing heat to rekindle dormant muscles and joints.


Formulated to warm the body and move stagnation in joints and muscles that have grown stiff over time.

This fast-acting topical moves with you, pairing a robust concentration of full-spectrum hemp extract with heating Chinese herbs to provide a deep, circulating warmth to areas of lingering discomfort.

Drawing from time-honored ‘dit da jow’ martial arts formulas, this high-potency blend encourages blood flow and thaws the "stuck" energy that makes movement feel like a chore to help you reclaim your daily mobility and stay active with ease. 


Because chronic stiffness shouldn’t be a barrier—and finding your flow should feel effortless.

An icy rush to comfort overworked muscles and joints.


Formulated to calm the body and clear excess heat following activity or physical stress. 

This fast-acting topical moves with you, pairing a robust concentration of full-spectrum hemp extract with cooling Chinese herbs to provide a steady, refreshing chill to areas of sudden sensitivity.

Drawing from time-honored ‘dit da jow’ martial arts formulas, this high-potency blend encourages circulation while systematically diffusing the "trapped" heat from overexertion to help you maintain balance and return to movement. 

Because recovery shouldn’t be a waiting game—and keeping your cool shouldn’t keep you frozen in place.

When Slightly More THC Is Clinically Appropriate

For pain severe enough to disrupt sleep — particularly the 3 to 5 AM waking pattern that is common in chronic pain — the trace THC in the Recovery Tincture may provide sufficient daytime coverage but insufficient support for nighttime pain arousal.


Sleep Gummies+ — formulated with 25mg CBD, 10mg CBN, and 2.5mg THC — provide both the sleep-supportive cannabinoid profile and the CB1 engagement that helps the nervous system release from pain-driven arousal during the second half of the night. The 2.5mg THC in this context is well within the low-dose clinical range and is formulated alongside sufficient CBD to modulate the psychoactive ceiling.


The intersection of pain and sleep is addressed fully in sleep and the pain cycle.

A restorative ritual to bridge effort and resilience.


Formulated to soothe the body and accelerate your return to movement. 

This precise blend of time-honored Chinese herbs and nano-encapsulated cannabinoids is designed to support the body's natural response to physical stress and enhance restoration. Whether used to shorten the recovery window after peak exertion or as a daily ritual to dissolve accumulated tension, this fast-acting formula works from the inside out to restore your natural momentum. 

Because your ability to bounce back shouldn’t be a bottleneck—and recovery should be as intentional as the effort itself.

The TCM Perspective on Cannabis as an Analgesic

Cannabis has a documented place in Chinese materia medica stretching back over two thousand years. It appears in the Shennong Bencao Jing — one of the foundational texts of classical Chinese herbology — for its ability to move Qi and blood stagnation and relieve pain.


In TCM terms, the analgesic action of cannabis maps precisely to its capacity to move stagnation. Where there is free flow of Qi and blood, there is no pain. Where flow is obstructed, pain accumulates. Cannabis moves flow. At clinically calibrated trace doses, this movement is therapeutic. At excess, it generates internal disharmony rather than resolving it.


Two thousand years of empirical observation and modern biphasic pharmacology describe the same biological reality in different languages.

Complete your protocol. Save 10% on any 2+ pain remedies.

Frequently Asked Questions About THC for Pain Relief

Does THC help with pain?

Direct Answer: Yes. At low doses, THC engages CB1 receptors in descending pain-inhibitory pathways to reduce pain signal intensity. It also demonstrates anti-inflammatory activity through CB2 receptor engagement at sub-psychoactive doses. The clinical benefit is dose-dependent and reverses at high doses.


Clinical Context: The most reliable pain outcomes with THC occur in low-dose, high-CBD-ratio full-spectrum formulas — not in isolation and not at recreational doses. The trace-THC, high-CBD Recovery Tincture represents the clinical standard: enough CB1 engagement to activate the analgesic pathway, with CBD modulating the psychoactive ceiling simultaneously.

Is THC or CBD better for pain?

Direct Answer: CBD and THC address pain through different receptor pathways that complement each other. Full-spectrum formulas combining both cannabinoids consistently outperform either in isolation for chronic pain management. See CBD for pain relief.


Clinical Context: CBD contributes CB2 anti-inflammatory activity, TRPV1 desensitization, and glycine receptor modulation. THC adds CB1 engagement in the descending pain-inhibitory pathway. These are additive, not competing mechanisms. The question is not which is better — it is how to use both at the right doses and ratios.

What is a low dose of THC for pain?

Direct Answer: In clinical contexts, 1 to 5mg THC is generally considered a low dose that produces analgesic CB1 engagement without consistent psychoactivity, particularly when combined with a 10:1 or higher CBD-to-THC ratio. Individual sensitivity varies significantly.


Clinical Context: Starting with trace-level THC in a full-spectrum CBD formula is the most conservative and clinically consistent entry point. Titrate upward only in small increments based on response. The goal is the CB1 analgesic effect — not the psychoactive ceiling.

Can THC reduce inflammation?

Direct Answer: Yes. THC engages CB2 receptors, which modulate immune cell activity and support a more regulated cytokine response. At sub-psychoactive doses, this CB2 engagement contributes an anti-inflammatory effect that complements CBD's mechanisms.


Clinical Context: Full-spectrum formulas with trace THC engage both the regulatory (CB2) and the pain-inhibitory (CB1) receptor systems simultaneously — which is why they outperform CBD isolate for inflammatory pain in clinical practice.

Will the Recovery Tincture make me feel high?

Direct Answer: No. The trace THC in the Recovery Tincture is formulated at sub-intoxicating levels alongside high CBD content that modulates its psychoactive ceiling. Standard doses will not produce intoxicating effects.


Clinical Context: The Recovery Tincture is formulated for daytime use and clinical mobility support. If you are highly THC-sensitive or have concerns about any psychoactive effect, consult a practitioner before use.

Does low-dose THC show up on a drug test?

Direct Answer: Yes. Even trace amounts of THC in full-spectrum formulas can accumulate in fat tissue and produce a positive result on urine drug screening. If drug testing is required, do not use full-spectrum formulas.


Clinical Context: Even full spectrum products like Wellness Tincture (60mg full-spectrum CBD) and Calming Gummies (25mg full-spectrum CBD) may show up on a test. Topical application of Warming or Cooling Balm is generally not expected to produce systemic THC levels sufficient to trigger a drug test, though no absolute guarantee applies.

Practitioner-Founded.
Rooted in Clinical Expertise.


Dragon Hemp was established by Kevin Menard, LAc, a specialist in Sports Medicine Acupuncture and Traditional Chinese Medicine. Developed in his Sag Harbor clinic, our formulations bridge the gap between ancient herbal wisdom and modern cannabinoid research to address the root causes of pain, sleep, and wellness issues.


From our Rest & Restoration and Essential Wellbeing collections to our targeted Aches & Pains topicals, every product is formulated with organically grown botanicals and premium hemp extracts. We invite you to experience our sophisticated fusion of tradition and innovation at our flagship apothecary at 108 Main Street, Sag Harbor, or explore our full range of tinctures, gummies, and balms online.


  • Learn more about our botanicals in our Ingredients Index.

  • Discover the design and ethos of our Sag Harbor apothecary in Forbes.
Kevin Menard, LAc., founder of Dragon Hemp and licensed acupuncturist specializing in Sports Medicine Acupuncture and Traditional Chinese Medicine.

Kevin Menard, LAc.

Kevin Menard, LAc., is the founder of Dragon Hemp and a licensed acupuncturist specializing in Sports Medicine Acupuncture and Traditional Chinese Medicine. He practices at his Sag Harbor clinic, where Dragon Hemp's formulas were developed.